Showing 781-790 of 8795 results for "".
Moisturizers for Skin Diseases: New Insights
https://practicaldermatology.com/topics/atopic-dermatitis/moisturizers-for-skin-diseases-new-insights/22977/Of Fitness, Friction, Fillers, and Fat: Pearls for Managing Active Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/of-fitness-friction-fillers-and-fat-pearls-for-managing-active-patients/23531/Help physically fit patients look as good as they feel.The Financial Contract Every Practice Must Have... And Very Few Do
https://practicaldermatology.com/topics/practice-management/the-financial-every-practice-must-have-and-very-few-do/21166/Risks of Multiple Primary Melanomas
https://practicaldermatology.com/topics/practice-management/risks-of-multiple-primary-melanomas/21058/Studies offer clarity on risks and patterns after diagnosis, as well as survival outcomes.Inside the Minds of Acne Patients
https://practicaldermatology.com/columns/clinical-focus-1/inside-the-minds-of-acne-patients/23634/Recommendations on how to start developing a treatment plan with its roots in the psychology of the acne patient.The Mind-Skin Connection: Psoriasis and Psychological Comorbidities
https://practicaldermatology.com/issues/supplements/the-mind-skin-connection-psoriasis-and-psychological-comorbidities/20833/Mechanism of Action Matters: A Review of New and Emerging Biologics
https://practicaldermatology.com/issues/supplements/mechanism-of-action-matters-a-review-of-new-and-emerging-biologics/23178/Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.